Reckitt Benckiser Group PLC
XMUN:3RB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Reckitt Benckiser Group PLC
XMUN:3RB
|
UK |
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
Wall St Price Targets
3RB Price Targets Summary
Reckitt Benckiser Group PLC
According to Wall Street analysts, the average 1-year price target for 3RB is 81.99 EUR with a low forecast of 67.08 EUR and a high forecast of 100.99 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3RB's stock price target?
Price Target
81.99
EUR
According to Wall Street analysts, the average 1-year price target for 3RB is 81.99 EUR with a low forecast of 67.08 EUR and a high forecast of 100.99 EUR.
What is the Revenue forecast for Reckitt Benckiser Group PLC?
Projected CAGR
2%
Over the last 8 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Reckitt Benckiser Group PLC?
Projected CAGR
2%
Over the last 8 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 2%.
What is the Net Income forecast for Reckitt Benckiser Group PLC?
Projected CAGR
0%
Over the last 8 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 5 years is 0%.
